SC 13G/A: BIOGEN INC.
Ticker: BIIB · Form: SC 13G/A · Filed: 2024-11-12T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by BIOGEN INC..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0000932471-24-000849 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0000932471-24-000849 Filing Date 2024-11-12 Accepted 2024-11-12 13:24:28 Documents 1 Document Format Files Seq Description Document Type Size 1 UnitedStates_13G__BiogenIncU.txt SC 13G/A 4972 Complete submission text file 0000932471-24-000849.txt 6784 Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 Business Address 100 VANGUARD BLVD MALVERN PA 19355 6106691000 VANGUARD GROUP INC (Filed by) CIK : 0000102909 (see all company filings) EIN. : 231945930 | State of Incorp.: PA | Fiscal Year End: 1231 Type: SC 13G/A Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142 Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000 BIOGEN INC. (Subject) CIK : 0000875045 (see all company filings) EIN. : 330112644 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-42028 | Film No.: 241446476 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)